Potential Ketoacidosis Linked to Imeglimin and Metformin Co-administration in a Patient With Type 2 Diabetes

A 74-year-old woman with type 2 diabetes mellitus developed ketoacidosis within six days of adding metformin to imeglimin treatment. The patient was insulin-sensitive and showed preserved insulin secretion; therefore, insulin insufficiency alone was unlikely to contribute to the development of ketoa...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamagishi, Hirofumi, Hoshino, Sachina, Hirano, Akiko, Oshima, Atsushi, Imai, Taihei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359143/
https://www.ncbi.nlm.nih.gov/pubmed/37485200
http://dx.doi.org/10.7759/cureus.40702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359143/
https://www.ncbi.nlm.nih.gov/pubmed/37485200
http://dx.doi.org/10.7759/cureus.40702

Ejemplares similares